EVOXAC Dosing Information
- The recommended dose of EVOXAC is 30 mg TID. There is insufficient safety information to support doses greater than 30 mg TID. There is also insufficient evidence for additional efficacy of EVOXAC at doses greater than 30 mg.
- Patient counseling on the importance of dosing compliance is recommended
- EVOXAC is available as white, hard gelatin capsules containing 30 mg of cevimeline hydrochloride. EVOXAC capsules have a white opaque cap and a white opaque body. The capsules are imprinted with “EVOXAC” on the cap and “30 mg” on the body with a black bar above “30 mg”. It is supplied in child resistant bottles of 100 capsules (NDC 63395-201-13). Store at 25°C (77°F) excursion permitted to 15°-30°C (59°-86°F).
For more information on the risks and benefits of EVOXAC, please see the full prescribing information.